InvestorsHub Logo
Followers 196
Posts 24680
Boards Moderated 0
Alias Born 04/03/2010

Re: Sharkee2 post# 448801

Saturday, 03/05/2022 6:15:06 PM

Saturday, March 05, 2022 6:15:06 PM

Post# of 701107
Biotech companies like this can often take more than a decade and sometimes two, and cell therapy companies or their technology, some get gobbled up for scrap just to take over the legacy technology and trials, can take longer.

I hear that 2015 seems like a long time, but if you wanted something faster I’d focus on certain segments of biotech rather than cell therapies.

I would not listen to CEO’s saying 2-3 or even 5 years and ever believing them in this space, because absolutely every aspect in these technologies is like reinventing the wheel at this stage of cell therapies. They are all doing it simultaneously and so are, unfortunately, the FDA and other regulators. The regulators still have a pharmaceutical model for trials, and they are learning slowly that that does not work with live medical products like cells that create dynamic responses that take more understanding and more complex trials to achieve a fuller understanding of the science and effects of such “drugs” or biological treatments.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News